The necessity of a second prostate biopsy cannot be predicted by PSA or PSA derivatives (density or free:total ratio) in men with prior negative prostatic biopsies

Current Opinion in Urology

Volumn 9, Issue 5, 1999, Pages 371-375

  Hayek, Omar R E ^a   Noble, Cyrus B ^a   De La Taille, Alexander ^a   Bagiella, Emilia ^a   Benson, Mitchell C ^a  

^a Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER SCREENING; CLINICAL EXAMINATION; DIAGNOSTIC PROCEDURE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM; SHORT SURVEY;

AGED; BIOPSY; DISEASE PROGRESSION; FALSE NEGATIVE REACTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0033397805     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199909000-00001     Document Type: Short Survey

References (24)

1. 1 Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147:817-821.
2. 2 Carter HB, Morrel CH, Pearson JD, Brant LJ, Plato CC, Metter EJ, et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res 1992; 52:3323-3328.
3. 3 Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270:860-864.
4. 4 Lilja H, Bjork T, Abrahamsson, Stenman, Shaw N, Dowell B, et al. Improved separation between normals, benign prostatic hyperplasia (BPH) and carcinoma of the prostate (CAP) by measuring free (F), complexed (C) and total concentrations (T) of prostate specific antigen (PSA). J Urol 1994; 151[abstract]:400A.
5. 5 Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ confined prostate cancer is increased through prostate specific antigen-based screening. J Am Med Assoc 1993; 271:192-193.
6. 6 Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1997. CA 1997; 47:5-27.
7. 7 Stenman UH, Leinonen J, Alfthan H, Ranniko S, Tuhkanen K, Alfthan O, et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51:222-226.
8. 8 Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, et al. Prostate-specific antigen in human serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991; 37:1618-1625.
9. 9 Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson G, Cuny C, et al. Measurement of the proportion of free to total prostate specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995; 46:187-194.
10. 10 Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff JL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995; 274:1214-1220.
11. 11 Alivizatos G, Deliveliotis C, Mitropoulos D, Raptides G, Louras G, Karayiannis A, et al. Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy? Urology 1996; 48(suppl):71-75.
12. 12 Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147(3 Pt 2):815-816.
13. 13 Ramon J, Boccon-Gibod L, Billebaud T, Astier L, Kobelinsky M, Meulemans A. A Prostate-specific antigen density: a means to enhance detection of prostate cancer. Eur Urol 1994; 25:288-294.
14. 14 Semjonow A, Hamm M, Rathert P. The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer. Urologie A 1993; 32:250-253.
15. 15 Benson MC, Olsson CA. Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management. Cancer 1994; 15:1667-1673.
16. 16 Benson MC, McMahon DJ, Cooner WH, Olsson CA. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density. World J Urol 1993; 11:206-213.
17. 17 Catalona WJ, Beiser JA, Smith DS. Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 1997; 158:2162-2167.
18. 18 Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol 1996; 156:428-431.
19. 19 Noguchi M, Yahara J, Koga H, Nakashima O, Noda S. Necessity of repeat biopsies in men for suspected prostate cancer. Int J Urol 1999; 6:7-12.
20. 20 Meshref AW, Bazinet M, Trudel C, et al. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges. Urology 1995; 45:972-979.
21. 21 Rietbergen JB, Kranse R, Hoedmaeker RF, Kruger AE, Bangma CH, Kirkels WJ, et al. Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study. Urology 1998; 52:237-246.
22. 22 Bangma CH, Kranse R, Blijenberg BG, Schroder. The free to total serum prostate specific antigen ratio for staging prostate carcinoma. J Urol 1997; 157:544-547.
23. 23 Douglas TH, Morgan TO, McLeod DG, Moul JW, Murphy GP, Barren R 3rd, et al. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients. Cancer 1997; 80:107-114.
24. 24 Egawa S, Suyama K, Soh S, Kuwao S, Uchida J, Koshiba K, et al. Inadequacy of free prostate-specific antigen parameters in the prediction of pathologic extent of prostate cancer in Japanese men. Urology 1998; 52:230-236.